BioMarin Pharma (NASDAQ: BMRN) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Corporate News FDA Hot Corp. News Hot FDA News Trader Talk

FDA Briefing Docs Offer Positives and Negatives for Sarepta (SRPT) - BairdNovember 23, 2015 6:55 AM BioMarin (BMRN) PT Trimmed at Wedbush Following Briefing Docs; Sees Positive Read-Thru to SRPT, None to PTCTNovember 20, 2015 12:33 PM Concerns on Drisapersen Positive for Sarepta's (SRPT) Eteplirsen - Needham & Company November 20, 2015 11:19 AM Despite Harsh BioMarin (BMRN) Briefing Docs, the Jury is Still Out - Leerink Partners November 20, 2015 10:21 AM BioMarin (BMRN) Has Good Risk/Reward Despite Cautious FDA Briefing Documents for Drisapersen, Says RBCNovember 20, 2015 10:12 AM BioMarin Pharma (BMRN) Briefing Docs 'Ugly' - Baird (SRPT)November 20, 2015 9:50 AM Sarepta Therapeutics (SRPT) Surges 25% Following BioMarin (BMRN) Briefing DocsNovember 20, 2015 8:36 AM BioMarin Pharma (BMRN) Announces Consistent Drisapersen Efficacy Evidence Demonstrated Across Three StudiesNovember 20, 2015 8:12 AM BioMarin Pharma (BMRN) Affirms Posting of Drisapersen NDA Briefing DocsNovember 20, 2015 8:11 AM